Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 19 Show results per page	View Search Criteria \| Help With Results


1.		A Phase II Trial of Adjuvant Radiation Therapy With Ifosfamide and Cisplatin in Patients With MMT of the Uterus

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				MMC-03-02-040 NCT00231842

Last Modified: 10/17/2008 First Published: 9/15/2006


2.		Phase II Study of Trabectedin in Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI				GOG-0087M GOG-0087M, NCT00379145

Last Modified: 2/1/2008 First Published: 10/14/2006


3.		Phase II Study of VEGF Trap in Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				18 and over				NCI				PMH-PHL-051 7502, NCI-7502, NCT00390234

Last Modified: 8/16/2008 First Published: 3/2/2007


4.		Phase II Study of Intrathecal Iodine I 131 Monoclonal Antibody 3F8 in Patients With GD2-Expressing Central Nervous System or Leptomeningeal Neoplasms

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				Any age				Other				MSKCC-05122 NCT00445965

Last Modified: 5/22/2008 First Published: 5/4/2007


5.		Phase II Pilot Study of Irradiated Allogeneic Related Donor Lymphocyte Infusion in Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				Any age				NCI				CINJ-3330 NCT00161187

Last Modified: 9/26/2007 First Published: 5/11/2007


6.		Phase II Study of Sunitinib Malate in Patients With Metastatic, Locally Advanced, or Locally Recurrent Non-Gastrointestinal Stromal Tumor Sarcomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI, Pharmaceutical / Industry				MSKCC-07054 07-054, PFIZER-MSKCC-07054, NCT00474994


7.		Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				06-063 NCT00476086


8.		Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				Not specified				Other				ID01-229 NCT00502203

Last Modified: 10/17/2008 First Published: 12/19/2007


9.		Phase II Study of Paclitaxel, Carboplatin, and BSI-201 in Patients With Persistent or Recurrent Stage III or IV Uterine Carcinosarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI				GOG-0232C GOG-0232C, NCT00588744


10.		Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				WalkerIP NCT00582205

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute